🇺🇸 FDA
Patent

US 9783501

Substituted quinolines as modulators of sodium channels

granted A61KA61K31/47A61K31/4709

Quick answer

US patent 9783501 (Substituted quinolines as modulators of sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/47, A61K31/4709, A61K31/498, A61P